![biaoTi](/_nuxt/img/biaoTi.0d1dc71.webp)
![biaoTi](/_nuxt/img/biaoTi.0d1dc71.webp)
Part 1
Part 2
Part 3
Part 5
Description
The global market for Microneedles for Trans & Intradermal Drug Delivery was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030. North American market for Microneedles for Trans & Intradermal Drug Delivery was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Microneedles for Trans & Intradermal Drug Delivery was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Microneedles for Trans & Intradermal Drug Delivery was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Microneedles for Trans & Intradermal Drug Delivery include Becton Dickinson, Nanopass Technologies, Radius Health, Clearside Biomedical, Dr. Prausnitz Group, Zosano Pharma, Corium International, Circassia and Valeritas, Inc., etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Microneedles for Trans & Intradermal Drug Delivery, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Microneedles for Trans & Intradermal Drug Delivery by region & country, by Type, and by Application.
The Microneedles for Trans & Intradermal Drug Delivery market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Microneedles for Trans & Intradermal Drug Delivery.
Market Segmentation
Report Metric
Details
Report Title
Microneedles for Trans & Intradermal Drug Delivery - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Global Microneedles for Trans & Intradermal Drug Delivery Companies Covered
Becton Dickinson, Nanopass Technologies, Radius Health, Clearside Biomedical, Dr. Prausnitz Group, Zosano Pharma, Corium International, Circassia, Valeritas, Inc., BD Medical
Global Microneedles for Trans & Intradermal Drug Delivery Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Microneedles for Trans & Intradermal Drug Delivery Market, Segment by Type
Solid Microneedles
Hollow Microneedles
Dissolvable Microneedles
Global Microneedles for Trans & Intradermal Drug Delivery Market, Segment by Application
Drugs
Vaccines
Proteins
Peptides
Others
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Microneedles for Trans & Intradermal Drug Delivery manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Microneedles for Trans & Intradermal Drug Delivery in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Microneedles for Trans & Intradermal Drug Delivery in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
1.1 Microneedles for Trans & Intradermal Drug Delivery Product Introduction
1.2 Global Microneedles for Trans & Intradermal Drug Delivery Market Size Forecast
1.2.1 Global Microneedles for Trans & Intradermal Drug Delivery Sales Value (2019-2030)
1.2.2 Global Microneedles for Trans & Intradermal Drug Delivery Sales Volume (2019-2030)
1.2.3 Global Microneedles for Trans & Intradermal Drug Delivery Sales Price (2019-2030)
1.3 Microneedles for Trans & Intradermal Drug Delivery Market Trends & Drivers
1.3.1 Microneedles for Trans & Intradermal Drug Delivery Industry Trends
1.3.2 Microneedles for Trans & Intradermal Drug Delivery Market Drivers & Opportunity
1.3.3 Microneedles for Trans & Intradermal Drug Delivery Market Challenges
1.3.4 Microneedles for Trans & Intradermal Drug Delivery Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered2 Competitive Analysis by Company
2.1 Global Microneedles for Trans & Intradermal Drug Delivery Players Revenue Ranking (2023)
2.2 Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Company (2019-2024)
2.3 Global Microneedles for Trans & Intradermal Drug Delivery Players Sales Volume Ranking (2023)
2.4 Global Microneedles for Trans & Intradermal Drug Delivery Sales Volume by Company Players (2019-2024)
2.5 Global Microneedles for Trans & Intradermal Drug Delivery Average Price by Company (2019-2024)
2.6 Key Manufacturers Microneedles for Trans & Intradermal Drug Delivery Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Microneedles for Trans & Intradermal Drug Delivery Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Microneedles for Trans & Intradermal Drug Delivery
2.9 Microneedles for Trans & Intradermal Drug Delivery Market Competitive Analysis
2.9.1 Microneedles for Trans & Intradermal Drug Delivery Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Microneedles for Trans & Intradermal Drug Delivery Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microneedles for Trans & Intradermal Drug Delivery as of 2023)
2.10 Mergers & Acquisitions, Expansion3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Solid Microneedles
3.1.2 Hollow Microneedles
3.1.3 Dissolvable Microneedles
3.2 Global Microneedles for Trans & Intradermal Drug Delivery Sales Value by Type
3.2.1 Global Microneedles for Trans & Intradermal Drug Delivery Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Microneedles for Trans & Intradermal Drug Delivery Sales Value, by Type (2019-2030)
3.2.3 Global Microneedles for Trans & Intradermal Drug Delivery Sales Value, by Type (%) (2019-2030)
3.3 Global Microneedles for Trans & Intradermal Drug Delivery Sales Volume by Type
3.3.1 Global Microneedles for Trans & Intradermal Drug Delivery Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Microneedles for Trans & Intradermal Drug Delivery Sales Volume, by Type (2019-2030)
3.3.3 Global Microneedles for Trans & Intradermal Drug Delivery Sales Volume, by Type (%) (2019-2030)
3.4 Global Microneedles for Trans & Intradermal Drug Delivery Average Price by Type (2019-2030)4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Drugs
4.1.2 Vaccines
4.1.3 Proteins
4.1.4 Peptides
4.1.5 Others
4.2 Global Microneedles for Trans & Intradermal Drug Delivery Sales Value by Application
4.2.1 Global Microneedles for Trans & Intradermal Drug Delivery Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Microneedles for Trans & Intradermal Drug Delivery Sales Value, by Application (2019-2030)
4.2.3 Global Microneedles for Trans & Intradermal Drug Delivery Sales Value, by Application (%) (2019-2030)
4.3 Global Microneedles for Trans & Intradermal Drug Delivery Sales Volume by Application
4.3.1 Global Microneedles for Trans & Intradermal Drug Delivery Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Microneedles for Trans & Intradermal Drug Delivery Sales Volume, by Application (2019-2030)
4.3.3 Global Microneedles for Trans & Intradermal Drug Delivery Sales Volume, by Application (%) (2019-2030)
4.4 Global Microneedles for Trans & Intradermal Drug Delivery Average Price by Application (2019-2030)5 Segmentation by Region
5.1 Global Microneedles for Trans & Intradermal Drug Delivery Sales Value by Region
5.1.1 Global Microneedles for Trans & Intradermal Drug Delivery Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Microneedles for Trans & Intradermal Drug Delivery Sales Value by Region (2019-2024)
5.1.3 Global Microneedles for Trans & Intradermal Drug Delivery Sales Value by Region (2025-2030)
5.1.4 Global Microneedles for Trans & Intradermal Drug Delivery Sales Value by Region (%), (2019-2030)
5.2 Global Microneedles for Trans & Intradermal Drug Delivery Sales Volume by Region
5.2.1 Global Microneedles for Trans & Intradermal Drug Delivery Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Microneedles for Trans & Intradermal Drug Delivery Sales Volume by Region (2019-2024)
5.2.3 Global Microneedles for Trans & Intradermal Drug Delivery Sales Volume by Region (2025-2030)
5.2.4 Global Microneedles for Trans & Intradermal Drug Delivery Sales Volume by Region (%), (2019-2030)
5.3 Global Microneedles for Trans & Intradermal Drug Delivery Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Microneedles for Trans & Intradermal Drug Delivery Sales Value, 2019-2030
5.4.2 North America Microneedles for Trans & Intradermal Drug Delivery Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Microneedles for Trans & Intradermal Drug Delivery Sales Value, 2019-2030
5.5.2 Europe Microneedles for Trans & Intradermal Drug Delivery Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Sales Value, 2019-2030
5.6.2 Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Microneedles for Trans & Intradermal Drug Delivery Sales Value, 2019-2030
5.7.2 South America Microneedles for Trans & Intradermal Drug Delivery Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Sales Value, 2019-2030
5.8.2 Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Sales Value by Country (%), 2023 VS 20306 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Microneedles for Trans & Intradermal Drug Delivery Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Microneedles for Trans & Intradermal Drug Delivery Sales Value
6.2.1 Key Countries/Regions Microneedles for Trans & Intradermal Drug Delivery Sales Value, 2019-2030
6.2.2 Key Countries/Regions Microneedles for Trans & Intradermal Drug Delivery Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Microneedles for Trans & Intradermal Drug Delivery Sales Value, 2019-2030
6.3.2 United States Microneedles for Trans & Intradermal Drug Delivery Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Microneedles for Trans & Intradermal Drug Delivery Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Microneedles for Trans & Intradermal Drug Delivery Sales Value, 2019-2030
6.4.2 Europe Microneedles for Trans & Intradermal Drug Delivery Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Microneedles for Trans & Intradermal Drug Delivery Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Microneedles for Trans & Intradermal Drug Delivery Sales Value, 2019-2030
6.5.2 China Microneedles for Trans & Intradermal Drug Delivery Sales Value by Type (%), 2023 VS 2030
6.5.3 China Microneedles for Trans & Intradermal Drug Delivery Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Microneedles for Trans & Intradermal Drug Delivery Sales Value, 2019-2030
6.6.2 Japan Microneedles for Trans & Intradermal Drug Delivery Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Microneedles for Trans & Intradermal Drug Delivery Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Microneedles for Trans & Intradermal Drug Delivery Sales Value, 2019-2030
6.7.2 South Korea Microneedles for Trans & Intradermal Drug Delivery Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Microneedles for Trans & Intradermal Drug Delivery Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Microneedles for Trans & Intradermal Drug Delivery Sales Value, 2019-2030
6.8.2 Southeast Asia Microneedles for Trans & Intradermal Drug Delivery Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Microneedles for Trans & Intradermal Drug Delivery Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Microneedles for Trans & Intradermal Drug Delivery Sales Value, 2019-2030
6.9.2 India Microneedles for Trans & Intradermal Drug Delivery Sales Value by Type (%), 2023 VS 2030
6.9.3 India Microneedles for Trans & Intradermal Drug Delivery Sales Value by Application, 2023 VS 20307 Company Profiles
7.1 Becton Dickinson
7.1.1 Becton Dickinson Company Information
7.1.2 Becton Dickinson Introduction and Business Overview
7.1.3 Becton Dickinson Microneedles for Trans & Intradermal Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Becton Dickinson Microneedles for Trans & Intradermal Drug Delivery Product Offerings
7.1.5 Becton Dickinson Recent Development
7.2 Nanopass Technologies
7.2.1 Nanopass Technologies Company Information
7.2.2 Nanopass Technologies Introduction and Business Overview
7.2.3 Nanopass Technologies Microneedles for Trans & Intradermal Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Nanopass Technologies Microneedles for Trans & Intradermal Drug Delivery Product Offerings
7.2.5 Nanopass Technologies Recent Development
7.3 Radius Health
7.3.1 Radius Health Company Information
7.3.2 Radius Health Introduction and Business Overview
7.3.3 Radius Health Microneedles for Trans & Intradermal Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Radius Health Microneedles for Trans & Intradermal Drug Delivery Product Offerings
7.3.5 Radius Health Recent Development
7.4 Clearside Biomedical
7.4.1 Clearside Biomedical Company Information
7.4.2 Clearside Biomedical Introduction and Business Overview
7.4.3 Clearside Biomedical Microneedles for Trans & Intradermal Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Clearside Biomedical Microneedles for Trans & Intradermal Drug Delivery Product Offerings
7.4.5 Clearside Biomedical Recent Development
7.5 Dr. Prausnitz Group
7.5.1 Dr. Prausnitz Group Company Information
7.5.2 Dr. Prausnitz Group Introduction and Business Overview
7.5.3 Dr. Prausnitz Group Microneedles for Trans & Intradermal Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Dr. Prausnitz Group Microneedles for Trans & Intradermal Drug Delivery Product Offerings
7.5.5 Dr. Prausnitz Group Recent Development
7.6 Zosano Pharma
7.6.1 Zosano Pharma Company Information
7.6.2 Zosano Pharma Introduction and Business Overview
7.6.3 Zosano Pharma Microneedles for Trans & Intradermal Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Zosano Pharma Microneedles for Trans & Intradermal Drug Delivery Product Offerings
7.6.5 Zosano Pharma Recent Development
7.7 Corium International
7.7.1 Corium International Company Information
7.7.2 Corium International Introduction and Business Overview
7.7.3 Corium International Microneedles for Trans & Intradermal Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Corium International Microneedles for Trans & Intradermal Drug Delivery Product Offerings
7.7.5 Corium International Recent Development
7.8 Circassia
7.8.1 Circassia Company Information
7.8.2 Circassia Introduction and Business Overview
7.8.3 Circassia Microneedles for Trans & Intradermal Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Circassia Microneedles for Trans & Intradermal Drug Delivery Product Offerings
7.8.5 Circassia Recent Development
7.9 Valeritas, Inc.
7.9.1 Valeritas, Inc. Company Information
7.9.2 Valeritas, Inc. Introduction and Business Overview
7.9.3 Valeritas, Inc. Microneedles for Trans & Intradermal Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Valeritas, Inc. Microneedles for Trans & Intradermal Drug Delivery Product Offerings
7.9.5 Valeritas, Inc. Recent Development
7.10 BD Medical
7.10.1 BD Medical Company Information
7.10.2 BD Medical Introduction and Business Overview
7.10.3 BD Medical Microneedles for Trans & Intradermal Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
7.10.4 BD Medical Microneedles for Trans & Intradermal Drug Delivery Product Offerings
7.10.5 BD Medical Recent Development8 Industry Chain Analysis
8.1 Microneedles for Trans & Intradermal Drug Delivery Industrial Chain
8.2 Microneedles for Trans & Intradermal Drug Delivery Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Microneedles for Trans & Intradermal Drug Delivery Sales Model
8.5.2 Sales Channel
8.5.3 Microneedles for Trans & Intradermal Drug Delivery Distributors9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. Microneedles for Trans & Intradermal Drug Delivery Market Trends
Table 2. Microneedles for Trans & Intradermal Drug Delivery Market Drivers & Opportunity
Table 3. Microneedles for Trans & Intradermal Drug Delivery Market Challenges
Table 4. Microneedles for Trans & Intradermal Drug Delivery Market Restraints
Table 5. Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Company (2019-2024)
Table 7. Global Microneedles for Trans & Intradermal Drug Delivery Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Microneedles for Trans & Intradermal Drug Delivery Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Microneedles for Trans & Intradermal Drug Delivery Price by Company (2019-2024) & (USD/Unit)
Table 10. Key Manufacturers Microneedles for Trans & Intradermal Drug Delivery Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Microneedles for Trans & Intradermal Drug Delivery Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Microneedles for Trans & Intradermal Drug Delivery
Table 13. Global Microneedles for Trans & Intradermal Drug Delivery Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microneedles for Trans & Intradermal Drug Delivery as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Microneedles for Trans & Intradermal Drug Delivery Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Microneedles for Trans & Intradermal Drug Delivery Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Microneedles for Trans & Intradermal Drug Delivery Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Microneedles for Trans & Intradermal Drug Delivery Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Microneedles for Trans & Intradermal Drug Delivery Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Microneedles for Trans & Intradermal Drug Delivery Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Microneedles for Trans & Intradermal Drug Delivery Price by Type (2019-2024) & (USD/Unit)
Table 27. Global Microneedles for Trans & Intradermal Drug Delivery Price by Type (2025-2030) & (USD/Unit)
Table 28. Global Microneedles for Trans & Intradermal Drug Delivery Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Microneedles for Trans & Intradermal Drug Delivery Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Microneedles for Trans & Intradermal Drug Delivery Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Microneedles for Trans & Intradermal Drug Delivery Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Microneedles for Trans & Intradermal Drug Delivery Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Microneedles for Trans & Intradermal Drug Delivery Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Microneedles for Trans & Intradermal Drug Delivery Price by Application (2019-2024) & (USD/Unit)
Table 39. Global Microneedles for Trans & Intradermal Drug Delivery Price by Application (2025-2030) & (USD/Unit)
Table 40. Global Microneedles for Trans & Intradermal Drug Delivery Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Microneedles for Trans & Intradermal Drug Delivery Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Microneedles for Trans & Intradermal Drug Delivery Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Microneedles for Trans & Intradermal Drug Delivery Sales Value by Region (2019-2024) & (%)
Table 44. Global Microneedles for Trans & Intradermal Drug Delivery Sales Value by Region (2025-2030) & (%)
Table 45. Global Microneedles for Trans & Intradermal Drug Delivery Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Microneedles for Trans & Intradermal Drug Delivery Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Microneedles for Trans & Intradermal Drug Delivery Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Microneedles for Trans & Intradermal Drug Delivery Sales Volume by Region (2019-2024) & (%)
Table 49. Global Microneedles for Trans & Intradermal Drug Delivery Sales Volume by Region (2025-2030) & (%)
Table 50. Global Microneedles for Trans & Intradermal Drug Delivery Average Price by Region (2019-2024) & (USD/Unit)
Table 51. Global Microneedles for Trans & Intradermal Drug Delivery Average Price by Region (2025-2030) & (USD/Unit)
Table 52. Key Countries/Regions Microneedles for Trans & Intradermal Drug Delivery Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Microneedles for Trans & Intradermal Drug Delivery Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Microneedles for Trans & Intradermal Drug Delivery Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Microneedles for Trans & Intradermal Drug Delivery Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Microneedles for Trans & Intradermal Drug Delivery Sales Volume, (2025-2030) & (K Units)
Table 57. Becton Dickinson Company Information
Table 58. Becton Dickinson Introduction and Business Overview
Table 59. Becton Dickinson Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 60. Becton Dickinson Microneedles for Trans & Intradermal Drug Delivery Product Offerings
Table 61. Becton Dickinson Recent Development
Table 62. Nanopass Technologies Company Information
Table 63. Nanopass Technologies Introduction and Business Overview
Table 64. Nanopass Technologies Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 65. Nanopass Technologies Microneedles for Trans & Intradermal Drug Delivery Product Offerings
Table 66. Nanopass Technologies Recent Development
Table 67. Radius Health Company Information
Table 68. Radius Health Introduction and Business Overview
Table 69. Radius Health Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 70. Radius Health Microneedles for Trans & Intradermal Drug Delivery Product Offerings
Table 71. Radius Health Recent Development
Table 72. Clearside Biomedical Company Information
Table 73. Clearside Biomedical Introduction and Business Overview
Table 74. Clearside Biomedical Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 75. Clearside Biomedical Microneedles for Trans & Intradermal Drug Delivery Product Offerings
Table 76. Clearside Biomedical Recent Development
Table 77. Dr. Prausnitz Group Company Information
Table 78. Dr. Prausnitz Group Introduction and Business Overview
Table 79. Dr. Prausnitz Group Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 80. Dr. Prausnitz Group Microneedles for Trans & Intradermal Drug Delivery Product Offerings
Table 81. Dr. Prausnitz Group Recent Development
Table 82. Zosano Pharma Company Information
Table 83. Zosano Pharma Introduction and Business Overview
Table 84. Zosano Pharma Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 85. Zosano Pharma Microneedles for Trans & Intradermal Drug Delivery Product Offerings
Table 86. Zosano Pharma Recent Development
Table 87. Corium International Company Information
Table 88. Corium International Introduction and Business Overview
Table 89. Corium International Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 90. Corium International Microneedles for Trans & Intradermal Drug Delivery Product Offerings
Table 91. Corium International Recent Development
Table 92. Circassia Company Information
Table 93. Circassia Introduction and Business Overview
Table 94. Circassia Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 95. Circassia Microneedles for Trans & Intradermal Drug Delivery Product Offerings
Table 96. Circassia Recent Development
Table 97. Valeritas, Inc. Company Information
Table 98. Valeritas, Inc. Introduction and Business Overview
Table 99. Valeritas, Inc. Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 100. Valeritas, Inc. Microneedles for Trans & Intradermal Drug Delivery Product Offerings
Table 101. Valeritas, Inc. Recent Development
Table 102. BD Medical Company Information
Table 103. BD Medical Introduction and Business Overview
Table 104. BD Medical Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 105. BD Medical Microneedles for Trans & Intradermal Drug Delivery Product Offerings
Table 106. BD Medical Recent Development
Table 107. Key Raw Materials Lists
Table 108. Raw Materials Key Suppliers Lists
Table 109. Microneedles for Trans & Intradermal Drug Delivery Downstream Customers
Table 110. Microneedles for Trans & Intradermal Drug Delivery Distributors List
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Microneedles for Trans & Intradermal Drug Delivery Product Picture
Figure 2. Global Microneedles for Trans & Intradermal Drug Delivery Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Microneedles for Trans & Intradermal Drug Delivery Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Microneedles for Trans & Intradermal Drug Delivery Sales Volume (2019-2030) & (K Units)
Figure 5. Global Microneedles for Trans & Intradermal Drug Delivery Sales Price (2019-2030) & (USD/Unit)
Figure 6. Microneedles for Trans & Intradermal Drug Delivery Report Years Considered
Figure 7. Global Microneedles for Trans & Intradermal Drug Delivery Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Microneedles for Trans & Intradermal Drug Delivery Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Microneedles for Trans & Intradermal Drug Delivery Revenue in 2023
Figure 10. Microneedles for Trans & Intradermal Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Solid Microneedles Picture
Figure 12. Hollow Microneedles Picture
Figure 13. Dissolvable Microneedles Picture
Figure 14. Global Microneedles for Trans & Intradermal Drug Delivery Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 15. Global Microneedles for Trans & Intradermal Drug Delivery Sales Value Market Share by Type, 2023 & 2030
Figure 16. Global Microneedles for Trans & Intradermal Drug Delivery Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 17. Global Microneedles for Trans & Intradermal Drug Delivery Sales Volume Market Share by Type, 2023 & 2030
Figure 18. Global Microneedles for Trans & Intradermal Drug Delivery Price by Type (2019-2030) & (USD/Unit)
Figure 19. Product Picture of Drugs
Figure 20. Product Picture of Vaccines
Figure 21. Product Picture of Proteins
Figure 22. Product Picture of Peptides
Figure 23. Product Picture of Others
Figure 24. Global Microneedles for Trans & Intradermal Drug Delivery Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 25. Global Microneedles for Trans & Intradermal Drug Delivery Sales Value Market Share by Application, 2023 & 2030
Figure 26. Global Microneedles for Trans & Intradermal Drug Delivery Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 27. Global Microneedles for Trans & Intradermal Drug Delivery Sales Volume Market Share by Application, 2023 & 2030
Figure 28. Global Microneedles for Trans & Intradermal Drug Delivery Price by Application (2019-2030) & (USD/Unit)
Figure 29. North America Microneedles for Trans & Intradermal Drug Delivery Sales Value (2019-2030) & (US$ Million)
Figure 30. North America Microneedles for Trans & Intradermal Drug Delivery Sales Value by Country (%), 2023 VS 2030
Figure 31. Europe Microneedles for Trans & Intradermal Drug Delivery Sales Value (2019-2030) & (US$ Million)
Figure 32. Europe Microneedles for Trans & Intradermal Drug Delivery Sales Value by Country (%), 2023 VS 2030
Figure 33. Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Sales Value (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Sales Value by Country (%), 2023 VS 2030
Figure 35. South America Microneedles for Trans & Intradermal Drug Delivery Sales Value (2019-2030) & (US$ Million)
Figure 36. South America Microneedles for Trans & Intradermal Drug Delivery Sales Value by Country (%), 2023 VS 2030
Figure 37. Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Sales Value (2019-2030) & (US$ Million)
Figure 38. Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Sales Value by Country (%), 2023 VS 2030
Figure 39. Key Countries/Regions Microneedles for Trans & Intradermal Drug Delivery Sales Value (%), (2019-2030)
Figure 40. Key Countries/Regions Microneedles for Trans & Intradermal Drug Delivery Sales Volume (%), (2019-2030)
Figure 41. United States Microneedles for Trans & Intradermal Drug Delivery Sales Value, (2019-2030) & (US$ Million)
Figure 42. United States Microneedles for Trans & Intradermal Drug Delivery Sales Value by Type (%), 2023 VS 2030
Figure 43. United States Microneedles for Trans & Intradermal Drug Delivery Sales Value by Application (%), 2023 VS 2030
Figure 44. Europe Microneedles for Trans & Intradermal Drug Delivery Sales Value, (2019-2030) & (US$ Million)
Figure 45. Europe Microneedles for Trans & Intradermal Drug Delivery Sales Value by Type (%), 2023 VS 2030
Figure 46. Europe Microneedles for Trans & Intradermal Drug Delivery Sales Value by Application (%), 2023 VS 2030
Figure 47. China Microneedles for Trans & Intradermal Drug Delivery Sales Value, (2019-2030) & (US$ Million)
Figure 48. China Microneedles for Trans & Intradermal Drug Delivery Sales Value by Type (%), 2023 VS 2030
Figure 49. China Microneedles for Trans & Intradermal Drug Delivery Sales Value by Application (%), 2023 VS 2030
Figure 50. Japan Microneedles for Trans & Intradermal Drug Delivery Sales Value, (2019-2030) & (US$ Million)
Figure 51. Japan Microneedles for Trans & Intradermal Drug Delivery Sales Value by Type (%), 2023 VS 2030
Figure 52. Japan Microneedles for Trans & Intradermal Drug Delivery Sales Value by Application (%), 2023 VS 2030
Figure 53. South Korea Microneedles for Trans & Intradermal Drug Delivery Sales Value, (2019-2030) & (US$ Million)
Figure 54. South Korea Microneedles for Trans & Intradermal Drug Delivery Sales Value by Type (%), 2023 VS 2030
Figure 55. South Korea Microneedles for Trans & Intradermal Drug Delivery Sales Value by Application (%), 2023 VS 2030
Figure 56. Southeast Asia Microneedles for Trans & Intradermal Drug Delivery Sales Value, (2019-2030) & (US$ Million)
Figure 57. Southeast Asia Microneedles for Trans & Intradermal Drug Delivery Sales Value by Type (%), 2023 VS 2030
Figure 58. Southeast Asia Microneedles for Trans & Intradermal Drug Delivery Sales Value by Application (%), 2023 VS 2030
Figure 59. India Microneedles for Trans & Intradermal Drug Delivery Sales Value, (2019-2030) & (US$ Million)
Figure 60. India Microneedles for Trans & Intradermal Drug Delivery Sales Value by Type (%), 2023 VS 2030
Figure 61. India Microneedles for Trans & Intradermal Drug Delivery Sales Value by Application (%), 2023 VS 2030
Figure 62. Microneedles for Trans & Intradermal Drug Delivery Industrial Chain
Figure 63. Microneedles for Trans & Intradermal Drug Delivery Manufacturing Cost Structure
Figure 64. Channels of Distribution (Direct Sales, and Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Description
The global market for Microneedles for Trans & Intradermal Drug Delivery was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030. North American market for Microneedles for Trans & Intradermal Drug Delivery was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Microneedles for Trans & Intradermal Drug Delivery was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Microneedles for Trans & Intradermal Drug Delivery was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Microneedles for Trans & Intradermal Drug Delivery include Becton Dickinson, Nanopass Technologies, Radius Health, Clearside Biomedical, Dr. Prausnitz Group, Zosano Pharma, Corium International, Circassia and Valeritas, Inc., etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Microneedles for Trans & Intradermal Drug Delivery, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Microneedles for Trans & Intradermal Drug Delivery by region & country, by Type, and by Application.
The Microneedles for Trans & Intradermal Drug Delivery market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Microneedles for Trans & Intradermal Drug Delivery.
Market Segmentation
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Microneedles for Trans & Intradermal Drug Delivery manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Microneedles for Trans & Intradermal Drug Delivery in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Microneedles for Trans & Intradermal Drug Delivery in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
English
Simon Lee
English
Hitesh
Chinese
Damon
Japanese
Tang Xin
Korean
Sung-Bin Yoon
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.
Fastest report delivery service
More than 17 years of vast experience
Operation for 24 * 7 & 365 days
In-depth and comprehensive analysis
Professional and timely after-sales service
Owns large database
English
Simon Lee
English
Hitesh
Chinese
Damon
Japanese
Tang Xin
Korean
Sung-Bin Yoon
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.
Fastest report delivery service
More than 17 years of vast experience
Operation for 24 * 7 & 365 days
In-depth and comprehensive analysis
Professional and timely after-sales service
Owns large database
Add to Cart
Buy Now